Federal Register MedWatch Pharma News Warning Letters
DAPIPRAZOLE HYDROCHLORIDE Solution/Drops; Ophthalmic 0.5% REV-EYES ANGELINI
For the most up-to-date approval information, please locate this API using the drug index.